Review



egfl7 recombinant protein  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Novus Biologicals egfl7 recombinant protein
    Egfl7 Recombinant Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/egfl7 recombinant protein/product/Novus Biologicals
    Average 86 stars, based on 8 article reviews
    egfl7 recombinant protein - by Bioz Stars, 2026-02
    86/100 stars

    Images



    Similar Products

    egfl7 recombinant protein  (Novus Biologicals)
    86
    Novus Biologicals egfl7 recombinant protein
    Egfl7 Recombinant Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/egfl7 recombinant protein/product/Novus Biologicals
    Average 86 stars, based on 1 article reviews
    egfl7 recombinant protein - by Bioz Stars, 2026-02
    86/100 stars
    		  Buy from Supplier
    recombinant human ve-statin/egfl7 gst (n-term) protein  (Bio-Techne corporation)
    90
    Bio-Techne corporation recombinant human ve-statin/egfl7 gst (n-term) protein
    Recombinant Human Ve Statin/Egfl7 Gst (N Term) Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human ve-statin/egfl7 gst (n-term) protein/product/Bio-Techne corporation
    Average 90 stars, based on 1 article reviews
    recombinant human ve-statin/egfl7 gst (n-term) protein - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    egfl7 recombinant protein h00051162-p01  (Novus Biologicals)
    90
    Novus Biologicals egfl7 recombinant protein h00051162-p01
    Egfl7 Recombinant Protein H00051162 P01, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/egfl7 recombinant protein h00051162-p01/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    egfl7 recombinant protein h00051162-p01 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    anti egfl7 antibody  (Novus Biologicals)
    86
    Novus Biologicals anti egfl7 antibody
    Anti Egfl7 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti egfl7 antibody/product/Novus Biologicals
    Average 86 stars, based on 1 article reviews
    anti egfl7 antibody - by Bioz Stars, 2026-02
    86/100 stars
    		  Buy from Supplier
    recombinant egfl7  (Novus Biologicals)
    90
    Novus Biologicals recombinant egfl7
    Sample distributions according to location and analysed parameters. <t>(EGFL7:</t> Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).
    Recombinant Egfl7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant egfl7/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    recombinant egfl7 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    h00051162 p01  (Novus Biologicals)
    90
    Novus Biologicals h00051162 p01
    Sample distributions according to location and analysed parameters. <t>(EGFL7:</t> Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).
    H00051162 P01, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h00051162 p01/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    h00051162 p01 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Sample distributions according to location and analysed parameters. (EGFL7: Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).

    Journal: Journal of Translational Medicine

    Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

    doi: 10.1186/s12967-014-0359-y

    Figure Lengend Snippet: Sample distributions according to location and analysed parameters. (EGFL7: Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).

    Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

    Techniques:

    Visualisation of EGFL7 and miRNA-126. Representative images of (A) : the intra-tumoural expression of Epidermal Growth Factor-like Domain 7 (EGFL7), by immunohistochemical analysis, showing staining of endothelial cells (ECs, brown) and the corresponding classified image (Ac) demonstrating intense staining of ECs (green) and faint staining (dark green) of myofibroblasts. Only the intense signal was included in the quantitative estimate. (B) The microRNA-126 (miRNA-126) in situ hybridization (ISH) analysis, showing merely exclusive intra-tumoural expression of ECs (blue) and the corresponding classified image (Bc) demonstrating the ECs included in the quantitative estimate (green).

    Journal: Journal of Translational Medicine

    Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

    doi: 10.1186/s12967-014-0359-y

    Figure Lengend Snippet: Visualisation of EGFL7 and miRNA-126. Representative images of (A) : the intra-tumoural expression of Epidermal Growth Factor-like Domain 7 (EGFL7), by immunohistochemical analysis, showing staining of endothelial cells (ECs, brown) and the corresponding classified image (Ac) demonstrating intense staining of ECs (green) and faint staining (dark green) of myofibroblasts. Only the intense signal was included in the quantitative estimate. (B) The microRNA-126 (miRNA-126) in situ hybridization (ISH) analysis, showing merely exclusive intra-tumoural expression of ECs (blue) and the corresponding classified image (Bc) demonstrating the ECs included in the quantitative estimate (green).

    Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

    Techniques: Expressing, Immunohistochemical staining, Staining, In Situ Hybridization

    Clinico-pathologic characteristics according to disease stage and relapse (N = 126)

    Journal: Journal of Translational Medicine

    Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

    doi: 10.1186/s12967-014-0359-y

    Figure Lengend Snippet: Clinico-pathologic characteristics according to disease stage and relapse (N = 126)

    Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

    Techniques:

    Dot plot illustrating the intra-tumoural expressions of Epidermal Growth Factor-like Domain 7 (EGFL7) in primary tumours according to stage (St.) and relapse free (−R) and relapsed (+R) patients, respectively (N = 123). See Table for statistical differences between the medians (represented by black bars).

    Journal: Journal of Translational Medicine

    Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

    doi: 10.1186/s12967-014-0359-y

    Figure Lengend Snippet: Dot plot illustrating the intra-tumoural expressions of Epidermal Growth Factor-like Domain 7 (EGFL7) in primary tumours according to stage (St.) and relapse free (−R) and relapsed (+R) patients, respectively (N = 123). See Table for statistical differences between the medians (represented by black bars).

    Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

    Techniques:

    Epidermal growth factor-like domain 7 (EGFL7) and microRNA-126 (miRNA-126) expressions in primary tumours and associated lymph node/distant metastases

    Journal: Journal of Translational Medicine

    Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

    doi: 10.1186/s12967-014-0359-y

    Figure Lengend Snippet: Epidermal growth factor-like domain 7 (EGFL7) and microRNA-126 (miRNA-126) expressions in primary tumours and associated lymph node/distant metastases

    Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

    Techniques: